Go Pro

Design Therapeutics (DSGN) Institutional Ownership

Design Therapeutics logo
$15.42 +0.14 (+0.92%)
Closing price 04:00 PM Eastern
Extended Trading
$14.85 -0.57 (-3.72%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Design Therapeutics (NASDAQ:DSGN)

Current
Institutional Ownership
Percentage
56.64%
Number of
Institutional Buyers
(last 12 months)
49
Total
Institutional Inflows
(last 12 months)
$55.67M
Number of
Institutional Sellers
(last 12 months)
25
Total
Institutional Outflows
(last 12 months)
$30.51M
Get DSGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Design Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

DSGN Institutional Buying and Selling by Quarter

Design Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE23,264$248K0.0%-15.2%0.037%
5/18/2026ADAR1 Capital Management LLC10,000$106K0.0%N/A0.016%
5/18/2026Royal Bank of Canada11,366$121K0.0%+1,681.5%0.018%
5/16/2026Quantinno Capital Management LP14,128$150K0.0%N/A0.023%
5/14/2026Renaissance Technologies LLC408,200$4.34M0.0%+42.2%0.654%
5/14/2026Public Employees Retirement System of Ohio15,193$162K0.0%+114.2%0.024%
5/14/2026Sei Investments Co.133,203$1.42M0.0%+152.6%0.213%
5/8/2026Baader Bank Aktiengesellschaft12,792$136K0.0%-36.0%0.020%
5/7/2026Dimensional Fund Advisors LP431,840$4.59M0.0%+45.0%0.691%
5/7/2026AlphaCentric Advisors LLC21,231$226K0.2%+4.8%0.034%
5/5/2026Bank of New York Mellon Corp79,645$847K0.0%-6.3%0.128%
4/25/2026Strs Ohio44,700$476K0.0%+77.4%0.072%
3/9/2026Corient Private Wealth LLC26,965$253K0.0%N/A0.047%
2/23/2026Virtu Financial LLC22,651$212K0.0%N/A0.040%
2/19/2026Invesco Ltd.305,757$2.87M0.0%+1,995.8%0.537%
2/19/2026Corient Private Wealth LLC26,965$253K0.0%N/A0.047%
2/18/2026XTX Topco Ltd35,284$331K0.0%+197.3%0.062%
2/18/2026Millennium Management LLC180,866$1.70M0.0%+162.8%0.318%
2/18/2026Elmind Capital LP207,900$1.95M0.6%N/A0.365%
2/18/2026Engineers Gate Manager LP14,012$131K0.0%N/A0.025%
2/18/2026Baker BROS. Advisors LP2,233,099$20.95M0.1%+30.4%3.920%
2/18/2026Bridgeway Capital Management LLC78,500$736K0.0%-58.3%0.138%
2/18/20269823 Capital L.P.19,197$180K0.1%N/A0.034%
2/17/2026Logos Global Management LP2,500,000$23.45M1.4%-31.6%4.389%
2/17/2026RA Capital Management L.P.1,461,381$13.71M0.1%+207.2%2.566%
2/17/2026Trexquant Investment LP99,967$938K0.0%N/A0.176%
2/17/2026Public Employees Retirement System of Ohio7,093$67K0.0%N/A0.012%
2/17/2026Diadema Partners LP100,320$941K0.2%N/A0.176%
2/17/2026Russell Investments Group Ltd.25,234$237K0.0%+295.7%0.044%
2/17/2026State of Wisconsin Investment Board50,657$475K0.0%+87.2%0.089%
2/17/2026Persistent Asset Partners Ltd34,989$328K0.1%N/A0.061%
2/16/2026Squarepoint Ops LLC46,142$433K0.0%N/A0.081%
2/16/2026Mariner LLC12,822$120K0.0%-20.3%0.023%
2/16/2026Frazier Life Sciences Management L.P.521,000$4.89M0.1%-73.3%0.915%
2/16/2026Kennedy Capital Management LLC50,023$469K0.0%+70.1%0.088%
2/16/2026Barclays PLC87,060$817K0.0%-1.3%0.153%
2/13/2026Marshall Wace LLP225,528$2.12M0.0%N/A0.396%
2/13/2026Vivo Capital LLC1,612,903$15.13M1.0%N/A2.832%
2/13/2026Jacobs Levy Equity Management Inc.194,611$1.83M0.0%N/A0.342%
2/13/2026Charles Schwab Investment Management Inc.236,863$2.22M0.0%-4.5%0.416%
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
2/13/2026State Street Corp647,636$6.08M0.0%+2.1%1.137%
2/13/2026Wells Fargo & Company MN26,786$251K0.0%+46.2%0.047%
2/12/2026MetLife Investment Management LLC15,249$143K0.0%+47.8%0.027%
2/12/2026Renaissance Technologies LLC287,100$2.69M0.0%+4.7%0.504%
2/12/2026Dimensional Fund Advisors LP297,921$2.80M0.0%+6.5%0.523%
2/12/2026AlphaCentric Advisors LLC20,262$190K0.2%N/A0.036%
2/12/2026Informed Momentum Co LLC78,949$741K0.1%N/A0.139%
2/12/2026Alps Advisors Inc.46,771$439K0.0%N/A0.082%
2/12/2026Nuveen LLC125,260$1.18M0.0%-5.8%0.220%
2/11/2026Deutsche Bank AG15,541$146K0.0%N/A0.027%
2/10/2026Goldman Sachs Group Inc.270,654$2.54M0.0%+3.5%0.475%
2/10/2026AXQ Capital LP11,728$110K0.0%N/A0.021%
2/10/2026Caz Investments LP3,500$33K0.1%-30.0%0.006%
2/9/2026Geode Capital Management LLC679,590$6.38M0.0%-2.3%1.193%
2/5/2026Baader Bank Aktiengesellschaft20,000$188K0.0%N/A0.035%
2/2/2026Strs Ohio25,200$236K0.0%+11.5%0.044%
1/30/2026Torren Management LLC2,820$26K0.0%N/A0.005%
1/21/2026Palumbo Wealth Management LLC69,377$651K0.2%+33.2%0.122%
1/1/2026JPMorgan Chase & Co.23,221$175K0.0%+26.7%0.041%
11/17/2025Woodline Partners LP612,712$4.61M0.0%-21.2%1.076%
11/17/2025Susquehanna International Group LLP14,023$106K0.0%-72.6%0.025%
11/17/2025RA Capital Management L.P.475,699$3.58M0.0%N/A0.835%
11/17/2025Millennium Management LLC68,823$518K0.0%N/A0.121%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,724$81K0.0%-40.3%0.019%
11/17/2025Citadel Advisors LLC554,020$4.17M0.0%-34.1%0.973%
11/14/2025Two Sigma Investments LP59,237$446K0.0%-33.7%0.104%
11/13/2025Kennedy Capital Management LLC29,411$221K0.0%+95.9%0.052%
11/13/2025Russell Investments Group Ltd.6,377$48K0.0%+69.6%0.011%
11/13/2025DLD Asset Management LP50,000$376K0.0%N/A0.088%
11/12/2025Dimensional Fund Advisors LP279,817$2.11M0.0%-10.7%0.491%
11/12/2025Caz Investments LP5,000$38K0.1%-33.3%0.009%
11/12/2025Intech Investment Management LLC14,155$107K0.0%-28.0%0.025%
11/10/2025Palumbo Wealth Management LLC52,081$392K0.1%-14.0%0.091%
11/10/2025China Universal Asset Management Co. Ltd.34,982$263K0.0%+206.8%0.061%
11/7/2025Vanguard Group Inc.1,443,701$10.87M0.0%-1.9%2.535%
11/7/2025JPMorgan Chase & Co.23,221$175K0.0%+26.7%0.041%
11/6/2025Rhumbline Advisers46,334$349K0.0%-4.1%0.081%
8/15/2025Caz Investments LP7,500$25K0.1%-50.0%0.013%
8/15/2025Bridgeway Capital Management LLC188,200$634K0.0%+65.4%0.330%
8/15/2025Bank of America Corp DE24,625$83K0.0%+11.1%0.043%
8/14/2025MPM Bioimpact LLC555,187$1.87M0.3%-1.4%0.975%
8/14/2025Jane Street Group LLC31,079$105K0.0%+71.5%0.055%
8/14/2025Velan Capital Investment Management LP20,000$67K0.1%+42.9%0.035%
8/13/2025Invesco Ltd.14,364$48K0.0%+26.8%0.025%
8/8/2025Geode Capital Management LLC794,008$2.68M0.0%+2.4%1.399%
8/7/2025Acadian Asset Management LLC627,348$2.11M0.0%-0.6%1.105%
8/7/2025Los Angeles Capital Management LLC12,735$43K0.0%N/A0.022%
7/11/2025 Assenagon Asset Management S.A.31,125$105K0.0%-15.7%0.055%
6/27/2025Goldman Sachs Group Inc.266,016$1.03M0.0%-10.5%0.469%
5/29/2025Rhumbline Advisers46,369$179K0.0%-12.4%0.082%
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
5/28/2025Strs Ohio22,600$87K0.0%N/A0.040%
5/21/2025Acadian Asset Management LLC630,953$2.43M0.0%+11.2%1.111%
5/19/2025Jane Street Group LLC18,125$70K0.0%N/A0.032%
5/16/2025Woodline Partners LP645,694$2.49M0.0%N/A1.137%
5/16/2025Goldman Sachs Group Inc.266,016$1.03M0.0%-10.5%0.469%
5/16/2025Almitas Capital LLC1,452,896$5.61M1.9%+9.8%2.559%
5/15/2025MPM Bioimpact LLC562,943$2.17M0.4%+0.6%0.992%
5/15/2025Velan Capital Investment Management LP14,000$54K0.1%N/A0.025%
5/15/2025Driehaus Capital Management LLC913,399$3.53M0.0%+17.7%1.609%
5/14/2025Wellington Management Group LLP141,519$546K0.0%N/A0.249%


DSGN Institutional Ownership - Frequently Asked Questions

During the previous two years, 89 institutional investors and hedge funds held shares of Design Therapeutics. The most heavily invested institutionals were Logos Global Management LP ($23.45M), Baker BROS. Advisors LP ($20.95M), Vivo Capital LLC ($15.13M), RA Capital Management L.P. ($13.71M), Point72 Asset Management L.P. ($11.46M), Vanguard Group Inc. ($10.87M), and Geode Capital Management LLC ($6.38M).Learn more on Design Therapeutics' institutional investors.

56.64% of Design Therapeutics' stock is owned by institutional investors. Learn more on DSGN's institutional investor holdings.

Of the 74 institutional investors that purchased Design Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($1.95M), Vivo Capital LLC ($1.61M), RA Capital Management L.P. ($1.46M), Point72 Asset Management L.P. ($1.26M), Driehaus Capital Management LLC ($913.40K), FMR LLC ($747.65K), and Woodline Partners LP ($645.69K).

Institutional investors have bought a total of 6,091,472 shares in the last 24 months. This purchase volume represents approximately $55.67M in transactions.

Of the 25 institutional investors that sold Design Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Frazier Life Sciences Management L.P. ($1.43M), Logos Global Management LP ($1.16M), Citadel Advisors LLC ($286.77K), Woodline Partners LP ($164.83K), Bridgeway Capital Management LLC ($109.70K), Susquehanna International Group LLP ($37.15K), and Dimensional Fund Advisors LP ($33.55K).

Institutional investors have sold a total of 3,385,298 shares in the last 24 months. This volume of shares sold represents approximately $30.51M in transactions.



This page (NASDAQ:DSGN) was last updated on 7/9/2026 by MarketBeat.com Staff.
From Our Partners